<DOC>
	<DOCNO>NCT01734889</DOCNO>
	<brief_summary>The purpose study verify pediatric patient , especially old enough swallow capsule , accept taste palatability new suspension .</brief_summary>
	<brief_title>Taste Palatability Orfadin Suspension</brief_title>
	<detailed_description>This open , non-randomized , non-controlled , multiple-dose study 18 pediatric patient . The treatment period three day , study subject rate taste palatability suspension ( young child ) parent rate childÂ´s acceptance suspension . The study consist screen period , 3 day treatment period 1 week follow-up period .</detailed_description>
	<mesh_term>Tyrosinemias</mesh_term>
	<mesh_term>Nitisinone</mesh_term>
	<criteria>Patients HT1 currently manage Orfadin ( nitisinone ) capsule . Age 1 month less 18 year . Signed informed consent . Any medical condition opinion investigator make subject unsuitable inclusion . Enrollment another concurrent clinical study , intake investigational medicinal product ( IMP ) , within one month prior inclusion study . Foreseeable inability cooperate give instruction study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>nitisinone</keyword>
	<keyword>Orfadin</keyword>
	<keyword>suspension</keyword>
	<keyword>taste</keyword>
	<keyword>acceptability</keyword>
</DOC>